Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II

NCT00796653 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

937

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Olodaterol (BI 1744)
DRUG: Olodaterol (BI 1744)
DRUG: Formoterol
DRUG: Placebo

Sponsor

Boehringer Ingelheim